期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Dynamic ^(18)F-fluorodeoxyglucose positron emission tomography/CT in hibernoma: enhanced tracer uptake mimicking liposarcoma
1
作者 Christos Sachpekidis Safwan Roumia +1 位作者 Matthias Schwarzbach Antonia Dimitrakopoulou-Strauss 《World Journal of Radiology》 CAS 2013年第12期498-502,共5页
We report on two cases of patients with fat-equivalent masses in computed tomography(CT),referred to our department for dynamic positron emission tomography/CT(dPET/CT)with18F-fluorodeoxyglucose(18FFDG)in order to inv... We report on two cases of patients with fat-equivalent masses in computed tomography(CT),referred to our department for dynamic positron emission tomography/CT(dPET/CT)with18F-fluorodeoxyglucose(18FFDG)in order to investigate their dignity.Both qualitative and quantitative information,as derived from dPET/CTs,couldn’t exclude a high-grade liposarcoma:Visual evaluation,revealed a large hypermetabolic focus of intense18F-FDG uptake in each patient(average SUVs 8.3 and 11.3).Regression-based parametric imaging demonstrated an enhanced distribution volume,which correlates to perfusion,and a high phosphorylation rate that correlates to cell viability.Kinetic analysis,based on a two-tissue compartment model demonstrated an enhanced FDG transport k1and an enhanced phosphorylation rate k3.A non-compartmental approach based on fractal dimension revealed also enhanced values.However,final diagnosis was based on biopsy,which revealed hibernoma,a benign brown fat tumor.Brown adipose contains increased numbers of mitochondria and a high-rate of glucose metabolism.Therefore,they have increased FDG uptake.The evaluation of lipomatous lesions on CT,with high FDG uptake,should include the possibility of hibernoma as a differential diagnosis. 展开更多
关键词 Hibernoma DYNAMIC POSITRON emission tomography/CT 18F-FLUORODEOXYGLUCOSE Kinetic Modeling Parametric imaging
下载PDF
PSMA配体的前列腺癌PET显像 被引量:3
2
作者 黎翔(译) 杨卫东(译) +9 位作者 汪静(审校) Sarah M.Schwarzenboeck Isabel Rauseher Christina Bluemel Wolfgang P.Fendler Steven P. Rowe Martin G.Pomper Ali Asfhar-Oromieh Ken Herrrnann Matthias Eiber 《中华核医学与分子影像杂志》 CAS 北大核心 2019年第2期121-128,共8页
近年来,用68Ga和18F标记PET显像剂靶向前列腺特异膜抗原(PSMA)逐渐受到重视。多项回顾性研究指出,与常规影像相比,PSMA配体前列腺癌PET/CT显像具有较高的检测效能,前列腺癌生化复发已被世界多个地区确立为PSMA配体前列腺癌PET/CT显像的... 近年来,用68Ga和18F标记PET显像剂靶向前列腺特异膜抗原(PSMA)逐渐受到重视。多项回顾性研究指出,与常规影像相比,PSMA配体前列腺癌PET/CT显像具有较高的检测效能,前列腺癌生化复发已被世界多个地区确立为PSMA配体前列腺癌PET/CT显像的临床适应证。对于高危原发前列腺癌,越来越多的证据表明该显像方式有助于探测隐匿性淋巴结和前列腺癌骨转移;对于原发和复发性前列腺癌的临床适应证,初步研究证实其对临床管理有着重要影响;另有证据表明,其对前列腺内的肿瘤定位、治疗分期和特定临床情况下的晚期病灶治疗监测将成为未来的适应证。随着有关生理性和病理性摄取模式和误区文献数量的剧增,PSMA配体PET显像报告的标准也在不断改进。文章旨在对PSMA配体PET显像的现状进行概述,包括显像程序和解释、临床适应证、诊断潜力及其对治疗计划的影响。 展开更多
关键词 前列腺癌 PET/CT PSMA
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部